Zheng X - Search Results

1

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial.

Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W. Zheng X, et al. Emerg Microbes Infect. 2023 Dec;12(1):2187247. doi: 10.1080/22221751.2023.2187247. Emerg Microbes Infect. 2023. PMID: 36872899 Free PMC article. Clinical Trial.

2

Risk factors for microbiological persistence after 6 months of treatment for Mycobacterium intracellulare and its impact on the drug-resistance profile.

Luo X, Zheng X, Fang Y, Yu F, Cui H, Sun Q, Sha W. Luo X, et al. Among authors: zheng x. Microbiol Spectr. 2023 Sep 25;11(5):e0080523. doi: 10.1128/spectrum.00805-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37747243 Free PMC article.

3

Comparative Proteomic Analysis of Exosomes Derived from Patients Infected with Non-Tuberculous Mycobacterium and Mycobacterium tuberculosis.

Wang L, Zheng X, Ma J, Gu J, Sha W. Wang L, et al. Among authors: zheng x. Microorganisms. 2023 Sep 17;11(9):2334. doi: 10.3390/microorganisms11092334. Microorganisms. 2023. PMID: 37764178 Free PMC article.

4

Correlation of drug exposure and bacterial susceptibility with treatment response for Mycobacterium avium complex lung disease: protocol for a prospective observational cohort study.

Zheng X, Wang L, Davies Forsman L, Zhang Y, Chen Y, Luo X, Liu Y, Bruchfeld J, Hu Y, Alffenaar JC, Sha W, Xu B. Zheng X, et al. BMJ Open. 2023 Oct 3;13(10):e075383. doi: 10.1136/bmjopen-2023-075383. BMJ Open. 2023. PMID: 37788924 Free PMC article.

5

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Zheng X, Davies Forsman L, Bao Z, Xie Y, Ning Z, Schön T, Bruchfeld J, Xu B, Alffenaar JW, Hu Y. Zheng X, et al. Eur Respir J. 2022 Mar 24;59(3):2101925. doi: 10.1183/13993003.01925-2021. Print 2022 Mar. Eur Respir J. 2022. PMID: 34737224 Free PMC article.

6

Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.

Shi W, Davies Forsman L, Hu Y, Zheng X, Gao Y, Li X, Jiang W, Bruchfeld J, Diwan VK, Hoffner S, Xu B. Shi W, et al. Among authors: zheng x. Int J Infect Dis. 2020 Jul;96:390-397. doi: 10.1016/j.ijid.2020.04.049. Epub 2020 Apr 27. Int J Infect Dis. 2020. PMID: 32353546 Free article.

7

Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.

Zheng X, Bao Z, Forsman LD, Hu Y, Ren W, Gao Y, Li X, Hoffner S, Bruchfeld J, Alffenaar JW. Zheng X, et al. Clin Infect Dis. 2021 Nov 2;73(9):e3520-e3528. doi: 10.1093/cid/ciaa1569. Clin Infect Dis. 2021. PMID: 33070176

8

Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment.

Zhang Y, Yu C, Jiang Y, Zheng X, Wang L, Li J, Shen X, Xu B. Zhang Y, et al. Among authors: zheng x. Clin Microbiol Infect. 2023 Mar;29(3):353-359. doi: 10.1016/j.cmi.2022.10.002. Epub 2022 Oct 6. Clin Microbiol Infect. 2023. PMID: 36209990 Free article.

9

Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.

Shi W, Hu Y, Zheng X, Ning Z, Wu M, Xia F, Prast-Nielsen S, Hu YOO, Xu B. Shi W, et al. Among authors: zheng x. BMC Pulm Med. 2019 Nov 11;19(1):211. doi: 10.1186/s12890-019-0981-9. BMC Pulm Med. 2019. PMID: 31711450 Free PMC article.

10

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study.

Davies Forsman L, Niward K, Hu Y, Zheng R, Zheng X, Ke R, Cai W, Hong C, Li Y, Gao Y, Werngren J, Paues J, Kuhlin J, Simonsson USH, Eliasson E, Alffenaar JW, Mansjö M, Hoffner S, Xu B, Schön T, Bruchfeld J. Davies Forsman L, et al. Among authors: zheng r, zheng x. BMJ Open. 2018 Oct 4;8(9):e023899. doi: 10.1136/bmjopen-2018-023899. BMJ Open. 2018. PMID: 30287613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22,946 results

Search Page